These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 33134121)
61. Delayed diagnosis and treatment of tuberculosis in HIV+ patients in Mozambique: A cost-effectiveness analysis of screening protocols based on four symptom screening, smear microscopy, urine LAM test and Xpert MTB/RIF. Orlando S; Triulzi I; Ciccacci F; Palla I; Palombi L; Marazzi MC; Giuliano M; Floridia M; Mancinelli S; Mutemba E; Turchetti G PLoS One; 2018; 13(7):e0200523. PubMed ID: 30024890 [TBL] [Abstract][Full Text] [Related]
62. Diagnosis of tuberculosis from smear-negative presumptive TB cases using Xpert MTB/Rif assay: a cross-sectional study from Nepal. Khadka P; Thapaliya J; Basnet RB; Ghimire GR; Amatya J; Rijal BP BMC Infect Dis; 2019 Dec; 19(1):1090. PubMed ID: 31888522 [TBL] [Abstract][Full Text] [Related]
63. Xpert MTB/RIF and Xpert Ultra assays for screening for pulmonary tuberculosis and rifampicin resistance in adults, irrespective of signs or symptoms. Shapiro AE; Ross JM; Yao M; Schiller I; Kohli M; Dendukuri N; Steingart KR; Horne DJ Cochrane Database Syst Rev; 2021 Mar; 3(3):CD013694. PubMed ID: 33755189 [TBL] [Abstract][Full Text] [Related]
64. The Xpert® MTB/RIF assay in routine diagnosis of pulmonary tuberculosis: A multicentre study in Lithuania. Pimkina E; Zablockis R; Nikolayevskyy V; Danila E; Davidaviciene E Respir Med; 2015 Nov; 109(11):1484-9. PubMed ID: 26403251 [TBL] [Abstract][Full Text] [Related]
65. A feasibility study of the Xpert MTB/RIF test at the peripheral level laboratory in China. Ou X; Xia H; Li Q; Pang Y; Wang S; Zhao B; Song Y; Zhou Y; Zheng Y; Zhang Z; Zhang Z; Li J; Dong H; Chi J; Zhang J; Kam KM; Huan S; Jun Y; Chin DP; Zhao Y Int J Infect Dis; 2015 Feb; 31():41-6. PubMed ID: 25447720 [TBL] [Abstract][Full Text] [Related]
66. Rifampicin resistance mutations in the 81 bp RRDR of rpoB gene in Mycobacterium tuberculosis clinical isolates using Xpert® MTB/RIF in Kampala, Uganda: a retrospective study. Mboowa G; Namaganda C; Ssengooba W BMC Infect Dis; 2014 Sep; 14():481. PubMed ID: 25190040 [TBL] [Abstract][Full Text] [Related]
67. Screening for HIV-associated tuberculosis and rifampicin resistance before antiretroviral therapy using the Xpert MTB/RIF assay: a prospective study. Lawn SD; Brooks SV; Kranzer K; Nicol MP; Whitelaw A; Vogt M; Bekker LG; Wood R PLoS Med; 2011 Jul; 8(7):e1001067. PubMed ID: 21818180 [TBL] [Abstract][Full Text] [Related]
68. Evaluating diagnostic performance of Truenat MTB Plus for gastrointestinal tuberculosis. Sharma K; Sharma M; Sharma V; Sharma M; Samanta J; Sharma A; Kochhar R; Sinha SK J Gastroenterol Hepatol; 2022 Aug; 37(8):1571-1578. PubMed ID: 35501293 [TBL] [Abstract][Full Text] [Related]
69. A diagnostic accuracy study of Xpert®MTB/RIF in HIV-positive patients with high clinical suspicion of pulmonary tuberculosis in Lima, Peru. Carriquiry G; Otero L; González-Lagos E; Zamudio C; Sánchez E; Nabeta P; Campos M; Echevarría J; Seas C; Gotuzzo E PLoS One; 2012; 7(9):e44626. PubMed ID: 22970271 [TBL] [Abstract][Full Text] [Related]
70. Factors Associated with Tuberculosis and Rifampicin-Resistant Tuberculosis amongst Symptomatic Patients in India: A Retrospective Analysis. Nair SA; Raizada N; Sachdeva KS; Denkinger C; Schumacher S; Dewan P; Kulsange S; Boehme C; Paramsivan CN; Arinaminpathy N PLoS One; 2016; 11(2):e0150054. PubMed ID: 26918818 [TBL] [Abstract][Full Text] [Related]
71. Implementing the Xpert® MTB/RIF Diagnostic Test for Tuberculosis and Rifampicin Resistance: Outcomes and Lessons Learned in 18 Countries. Ardizzoni E; Fajardo E; Saranchuk P; Casenghi M; Page AL; Varaine F; Kosack CS; Hepple P PLoS One; 2015; 10(12):e0144656. PubMed ID: 26670929 [TBL] [Abstract][Full Text] [Related]
72. The New Xpert MTB/RIF Ultra: Improving Detection of Chakravorty S; Simmons AM; Rowneki M; Parmar H; Cao Y; Ryan J; Banada PP; Deshpande S; Shenai S; Gall A; Glass J; Krieswirth B; Schumacher SG; Nabeta P; Tukvadze N; Rodrigues C; Skrahina A; Tagliani E; Cirillo DM; Davidow A; Denkinger CM; Persing D; Kwiatkowski R; Jones M; Alland D mBio; 2017 Aug; 8(4):. PubMed ID: 28851844 [TBL] [Abstract][Full Text] [Related]
73. Analysis of drug resistance mutations in pulmonary Mycobacterium tuberculosis isolates in the Southern coastal region of Andhra Pradesh, India. Polu GP; Mohammad Shaik J; Kota NMK; Karumanchi D; Allam US Braz J Infect Dis; 2019; 23(5):281-290. PubMed ID: 31421108 [TBL] [Abstract][Full Text] [Related]
74. Operational challenges in diagnosing multi-drug resistant TB and initiating treatment in Andhra Pradesh, India. Chadha SS; Sharath BN; Reddy K; Jaju J; Vishnu PH; Rao S; Parmar M; Satyanarayana S; Sachdeva KS; Wilson N; Harries AD PLoS One; 2011; 6(11):e26659. PubMed ID: 22073182 [TBL] [Abstract][Full Text] [Related]
75. [Accuracy of Xpert Feng JN; Gao L; Sun YX; Yang JC; Deng SW; Sun F; Zhan SY Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Oct; 53(2):320-326. PubMed ID: 33879905 [TBL] [Abstract][Full Text] [Related]
76. Xpert MTB/RIF for rapid detection of rifampicin-resistant Mycobacterium tuberculosis from pulmonary tuberculosis patients in Southwest Ethiopia. Tadesse M; Aragaw D; Dimah B; Efa F; Abebe G Int J Mycobacteriol; 2016 Dec; 5 Suppl 1():S48-S49. PubMed ID: 28043605 [TBL] [Abstract][Full Text] [Related]
77. Performance evaluation of Xpert MTB/RIF in a moderate tuberculosis incidence compared with TaqMan MTB and TRCRapid M.TB. Tsuyuguchi K; Nagai H; Ogawa K; Matsumoto T; Morimoto K; Takaki A; Mitarai S J Infect Chemother; 2017 Feb; 23(2):101-106. PubMed ID: 27919693 [TBL] [Abstract][Full Text] [Related]
78. The new Xpert Mycobacterium tuberculosis/rifampicin (MTB/Rif) Ultra assay in comparison to Xpert MTB/Rif assay for diagnosis of tuberculosis in children and adolescents. Kaur H; Guglani V; Singhal L; Randev S; Kumar P; Gupta V J Trop Pediatr; 2023 Dec; 70(1):. PubMed ID: 38116810 [TBL] [Abstract][Full Text] [Related]
79. Line probe assay test in new cases of tuberculosis with rifampicin resistance not detected by Xpert MTB/RIF. Soedarsono S; Mertaniasih NM; Hasan H; Kusmiati T; Permatasari A; Kusumaningrum D; Wijaksono W Int J Mycobacteriol; 2022; 11(4):429-434. PubMed ID: 36510930 [TBL] [Abstract][Full Text] [Related]